Home |
Free Dividend Report |
Stock Splits Calendar |
CYCC Historical Stock Prices |
CYCC Preferred Stock |
CYCC Options Chain |
Stock Message Boards |
Cyclacel Pharmaceuticals (CYCC) has the following price history information. Looking back at CYCC historical stock prices for the last five trading days, on April 19, 2024, CYCC opened at $1.89, traded as high as $1.95 and as low as $1.77, and closed at $1.78. Trading volume was a total of 10.30K shares. On April 22, 2024, CYCC opened at $1.80, traded as high as $1.93 and as low as $1.73, and closed at $1.75. Trading volume was a total of 25.50K shares. On April 23, 2024, CYCC opened at $1.71, traded as high as $1.85 and as low as $1.68, and closed at $1.79. Trading volume was a total of 28.40K shares. On April 24, 2024, CYCC opened at $1.86, traded as high as $2.35 and as low as $1.85, and closed at $2.30. Trading volume was a total of 551.10K shares. On April 25, 2024, CYCC opened at $1.78, traded as high as $1.99 and as low as $1.41, and closed at $1.60. Trading volume was a total of 3.47M shares.
CYCC Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Cyclacel Pharmaceuticals shares, starting with a $10,000 purchase of CYCC, and working forward through the historical stock price information to today.
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 04/29/2014 | |
End date: | 04/25/2024 | |
Start price/share: | $12,096.00 | |
End price/share: | $1.60 | |
Dividends collected/share: | $0.00 | |
Total return: | -99.99% | |
Average Annual Total Return: | -59.07% | |
Starting investment: | $10,000.00 | |
Ending investment: | $1.32 | |
Years: | 10.00 |
CYCC Historical Price Range | |||||
Date | Open | High | Low | Close | Volume |
04/19/2024 | $1.89 | $1.95 | $1.77 | $1.78 | 10.30K |
04/22/2024 | $1.80 | $1.93 | $1.73 | $1.75 | 25.50K |
04/23/2024 | $1.71 | $1.85 | $1.68 | $1.79 | 28.40K |
04/24/2024 | $1.86 | $2.35 | $1.85 | $2.30 | 551.10K |
04/25/2024 | $1.78 | $1.99 | $1.41 | $1.60 | 3.47M |
About Cyclacel Pharmaceuticals |
Cyclacel Pharmaceuticals is a biopharmaceutical company engaged in developing cancer medicines based on cell cycle, transcriptional regulation and mitosis control biology. The transcriptional regulation program is evaluating fadraciclib, a Cyclin Dependent Kinase 2/9 (CDK2/9) inhibitor, in solid tumors and hematological malignancies. CDKs also provide pivotal functions in the regulation of transcription, DNA repair and metastatic spread. The anti-mitotic program is evaluating plogosertib, a polo-like kinase, or PLK inhibitor, in solid tumors and hematological malignancies. PLK1 is a serine/threonine kinase with a central role in cell division, or the mitotic phase of the cell cycle. |
CYCC Historical Closing Prices | |
Date | Close |
04/19/2024 | $1.78 |
04/22/2024 | $1.75 |
04/23/2024 | $1.79 |
04/24/2024 | $2.30 |
04/25/2024 | $1.60 |
Healthcare Historical Prices |
CYCC is categorized under the Healthcare sector; below are some other companies in the same sector:
CYH Historical Stock Prices Also explore: CYCC shares outstanding history
Free CYCC Email Alerts:
|
CYCC Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved
Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.Want to receive our latest research absolutely free?
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.